Akebia Therapeutics
AKBA
#7494
Rank
NZ$0.70 B
Marketcap
NZ$2.67
Share price
-3.14%
Change (1 day)
-22.37%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: NZ$0.70 Billion

As of December 2025 Akebia Therapeutics has a market cap of NZ$0.70 Billion. This makes Akebia Therapeutics the world's 7494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.70 B-6.23%
2024NZ$0.75 B104.23%
2023NZ$0.36 B120.95%
2022NZ$0.16 B-71.12%
2021NZ$0.57 B3.21%
2020NZ$0.56 B-50.88%
2019NZ$1.14 B18.49%
2018NZ$0.96 B-2.63%
2017NZ$0.98 B71.84%
2016NZ$0.57 B-0.5%
2015NZ$0.57 B91.27%
2014NZ$0.30 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Akebia Therapeutics was reported to be:

NZ$0.70 Billion
by Nasdaq info icon info icon
NZ$0.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$307.49 B 43,368.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.96 B 61,952.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
NZ$842.14 B 118,948.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$2.00 B 183.22%๐Ÿ‡บ๐Ÿ‡ธ USA